Elizabeth Homans

Former Chief Executive Officer and Director\

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

LYEL

CEO, Board Member

2020-01-01–2022-12-15

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Lyell Immunopharma, Inc. (LYEL)	Former Chief Executive Officer and Director	$647,036	—	—	$10,130,622	—	$1,341,946	$12,119,604
2021	Lyell Immunopharma, Inc. (LYEL)	Former Chief Executive Officer and Director	$549,069	$100,116	—	$17,654,715	$333,720	$5,949	$18,643,569
2020	Lyell Immunopharma, Inc. (LYEL)	Former Chief Executive Officer and Director	$493,981	$327,250	—	$17,730,122	$309,000	$8,922	$18,869,275

No earnings-call appearances or filed executive changes recorded yet.